Insights into TNXB-Related Classical-Like Ehlers-Danlos Syndrome: A Study of Polish Patients
Abstract
Objective: Ehlers-Danlos syndromes (EDS) are a heterogeneous group of heritable connective tissue disorders with diverse clinical and genetic backgrounds. Classical-like EDS (clEDS, OMIM 606408) is an extremely rare autosomal recessive subtype caused by biallelic variants in TNXB. Fewer than 100 cases have been described worldwide. This study aimed to identify and characterise TNXB-related variants in two Polish patients with clinical features suggestive of clEDS.
Methods: Two male patients, aged 13 and 14 years, underwent comprehensive genetic testing, including next-generation sequencing (NGS) using a connective tissue gene panel, Multiplex Ligation-dependent Probe Amplification (MLPA), and Sanger sequencing. Family segregation analysis was performed to confirm compound heterozygosity.
Results: NGS and confirmatory analyses identified compound heterozygous TNXB variants: c.[7222C>T];[8780T>C], p.[Pro2408Ser];[Ile2927Thr] in Patient 1, and c.[5947_5948delinsTT];[8300C>T], p.[Glu1983Leu];[Thr2767Ile] in Patient 2. Both variants were located in non-homologous TNXB exons, minimising the risk of misinterpretation due to pseudogene sequences. The clinical presentations of both patients were consistent with the major diagnostic criteria for classical-like EDS.
Conclusion: This report presents the first genetically confirmed Polish patients with a classical-like form of Ehlers-Danlos syndrome, expanding the known clinical and molecular spectrum of TNXB-related EDS. Our findings…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.